A 60-y-old chylomicronemia patient homozygous for missense mutation (G188E) in the lipoprotein lipase gene showed no accelerated atherosclerosis

被引:21
作者
Ebara, Tetsu
Endo, Yoriko
Yoshiike, Shouichi
Tsuji, Masatomi
Taguchi, Susumu
Murase, Toshio
Okubo, Minoru
机构
[1] Okinaka Mem Inst Med Res, Minato Ku, Tokyo 1058470, Japan
[2] Showa Univ No, Yokohama Hosp, Dept Internal Med, Tsuzuki Ku, Yokohama, Kanagawa 2248503, Japan
[3] Roranomon Hosp, Dept Endocrinol & Metab, Tokyo, Japan
关键词
lipoprotein lipase deficiency; chylomicronemia; point mutation; atherosclerosis; mechanical multidetector-row computer tomography;
D O I
10.1016/j.cca.2007.08.011
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Familial lipoprotein lipase (LPL) deficiency is a rare autosomal recessive disorder caused by mutations in the LPL gene. Patients with LPL deficiency have chylomicronemia; however, whether they develop accelerated atherosclerosis remains unclear. Methods: We investigated clinical and mutational characteristics of a 60-y-old Japanese patient with chylomicronemia. Results: The patient's fasting plasma triglyceride levels were >9.0 mmol/l. In postheparin plasma, one fifth of the normal LPL protein mass was present; however, LPL activity was undetectable. Molecular analysis of the LPL gene showed the patient to be a homozygote of missense mutation replacing glycine with glutamine at codon 188 (G188E), which had been known to produce mutant LPL protein lacking lipolytic activity. Ultrasonographic examination of the patient's carotid and femoral arteries showed no accelerated atherosclerosis. Moreover, 64-slice mechanical multidetector-row computer tomography (MDCT) angiography did not detect any accelerated atherosclerotic lesions in the patient's coronary arteries. The patient had none of the risk factors such as smoking, hypertension, and diabetes. Conclusions: Our case suggests that accelerated atherosclerosis may not develop in patients with LPL deficiency, when they have no risk factors. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:100 / 104
页数:5
相关论文
共 26 条
[11]  
HATA A, 1992, J BIOL CHEM, V267, P20132
[12]  
HIXSON JE, 1990, J LIPID RES, V31, P545
[13]   INITIAL DIAGNOSIS OF LIPOPROTEIN-LIPASE DEFICIENCY IN A 75-YEAR-OLD MAN [J].
HOEG, JM ;
OSBORNE, JC ;
GREGG, RE ;
BREWER, HB .
AMERICAN JOURNAL OF MEDICINE, 1983, 75 (05) :889-892
[14]   Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPLArita in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis [J].
Kawashiri, M ;
Higashikata, T ;
Mizuno, M ;
Takata, M ;
Katsuda, S ;
Miwa, K ;
Nozue, T ;
Nohara, A ;
Inazu, A ;
Kobayashi, J ;
Koizumi, J ;
Mabuchi, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12) :6541-6544
[15]   Lipoprotein lipase: genetics, lipid uptake, and regulation [J].
Merkel, M ;
Eckel, RH ;
Goldberg, IJ .
JOURNAL OF LIPID RESEARCH, 2002, 43 (12) :1997-2006
[16]   A MISSENSE MUTATION AT CODON-188 OF THE HUMAN LIPOPROTEIN-LIPASE GENE IS A FREQUENT CAUSE OF LIPOPROTEIN-LIPASE DEFICIENCY IN PERSONS OF DIFFERENT ANCESTRIES [J].
MONSALVE, MV ;
HENDERSON, H ;
ROEDERER, G ;
JULIEN, P ;
DEEB, S ;
KASTELEIN, JJP ;
PERITZ, L ;
DEVLIN, R ;
BRUIN, T ;
MURTHY, MRV ;
CAGNE, C ;
DAVIGNON, J ;
LUPIEN, PJ ;
BRUNZELL, JD ;
HAYDEN, MR .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :728-734
[17]   DECLINE OF POST-HEPARIN PLASMA-LIPOPROTEIN LIPASE IN ACROMEGALIC PATIENTS [J].
MURASE, T ;
YAMADA, N ;
OHSAWA, N ;
KOSAKA, K ;
MORITA, S ;
YOSHIDA, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1980, 29 (07) :666-672
[18]   Detection of a new compound heterozygote (del G916/G1401A) for lipoprotein lipase deficiency and a comparative haplotype analysis of the mutant lipoprotein lipase gene from Japanese patients [J].
Okubo, M ;
Inoue, S ;
Horinishi, A ;
Ogihara, T ;
Kaneko, K ;
Gotoda, T ;
Yamada, N ;
Murase, T .
ATHEROSCLEROSIS, 1999, 144 (02) :443-447
[19]  
Peterson J, 2002, J LIPID RES, V43, P398
[20]   Novel LPL mutation (L303F) found in a patient associated with coronary artery disease and severe systemic atherosclerosis [J].
Saika, Y ;
Sakai, N ;
Takahashi, M ;
Maruyama, T ;
Kihara, S ;
Ouchi, N ;
Ishigami, M ;
Hiraoka, H ;
Nakamura, T ;
Yamashita, S ;
Matsuzawa, Y .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (03) :216-222